Desvenlafaxine
Desvenlafaxine, Khedezla (desvenlafaxine) is a small molecule pharmaceutical. Desvenlafaxine was first approved as Desvenlafaxine on 2013-03-04. It is used to treat major depressive disorder in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target sodium-dependent dopamine transporter.
| Trade Name | Desvenlafaxine, Khedezla |
|---|---|
| Common Name | Desvenlafaxine |
| Indication | major depressive disorder |
| Drug Class | Antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake |
